ORGANICELL REGENERATIVE MEDICINE
Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine. It is driven by a mission is to transform regenerative medicine by continuing to combine exosome technology with other synergistic therapies and become the healthcare technology incubator for biologic medicine. The company was founded in 2014 and is headquartered in Miami, Florida.
ORGANICELL REGENERATIVE MEDICINE
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2014-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.organicell.com
Total Employee:
11+
Status:
Active
Contact:
888)963-7881
Email Addresses:
[email protected]
Total Funding:
4.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Sitelinks Search Box Euro Organization Schema
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.organicell.com Semrush global rank: 2.65 M Semrush visits lastest month: 6.42 K
- Host name: 221.78.167.72.host.secureserver.net
- IP address: 72.167.78.221
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Organicell Regenerative Medicine"
Organicell Regenerative Medicine - Crunchbase
Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine. It is driven by a mission is to transform regenerative medicine by continuing to combine exosome …See details»
Organicell Regenerative Medicine Rebranding to ZEO ScientifiX
Mar 4, 2024 ZEO ScientifiX's Chief Executive Officer, Harry Leider, MD, MBA commented, "We are delighted about our name change to ZEO as it communicates the energy and creativity …See details»
Organicell Regenerative Medicine - Contacts, Employees, Board …
Organization. Organicell Regenerative Medicine . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. …See details»
Organicell Regenerative Medicine, Inc. Announces Expansion of ...
Sep 20, 2022 Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative biological therapeutics …See details»
Organicell Announces FDA Approval Of IND Application For The …
Jul 21, 2021 Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR) is a clinical-stage biopharmaceutical company that harnesses the power of exosomes to develop innovative …See details»
Organicell Regenerative Medicine - Funding, Financials, Valuation ...
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... Aug 16, 2021: Seed Round - Organicell Regenerative Medicine — …See details»
Organicell Announces Matt Sinnreich as CEO - BioSpace
Jul 26, 2022 Organicell Regenerative Medicine, Inc . (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological …See details»
Organicell™ Announces FDA Approval Of IND …
Miami, FL (July 21, 2021) — Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food …See details»
Organicell Regenerative Medicine, Inc. Secures Additional $11 …
Sep 9, 2022 Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative biological therapeutics …See details»
Organicell And Proxima CRO Set To Open Clinical Trial For Long …
Feb 8, 2022 The trial, organized and operated through Proxima Clinical Research, a Houston-based contract research organization, is anticipated to enroll over a 12-month period with the …See details»
Organicell To Present Results Of Zofin - Business Wire
May 25, 2021 Organicell’s work, which was selected for an oral presentation, will be part of a session titled: ... For more information about the organization, please visit: isctglobal.org.See details»
Organicell Regenerative Medicine and Its ... - Business Wire
Dec 29, 2020 Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) is a clinical-stage biopharmaceutical company that is seeking to harness the power of nanoparticles to develop …See details»
FINRA Approves Marketplace Name Change to Organicell …
Nov 5, 2021 Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR) is a clinical-stage biopharmaceutical company that harnesses the power of exosomes to develop innovative …See details»
Organicell Announces FDA Approval of IND Application for the …
Jan 28, 2021 Rosh Lowe Organicell Regenerative Medicine, Inc. 786-290-4400 [email protected] Media Contact: Jeffrey Freedman RooneyPartners 646-432-0191 …See details»
Organicell Reports Interim Results of Phase 1/2A Research Program
Jul 26, 2023 Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative biological regenerative …See details»
FDA Approves Two Emergency INDs to Administer Organicell
May 19, 2020 Organicell has no intention and specifically disclaims any duty to update the information in this press release. Media Contact: RooneyPartners Marion Janic 646-537-5649 …See details»
Organicell Announces FDA Approval Of IND Application For The …
Jul 21, 2021 Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR) is a clinical-stage biopharmaceutical company that harnesses the power of exosomes to develop innovative …See details»
Organicell Launches Autologous Blood Derived Platform
Jun 9, 2021 Organicell has no intention and specifically disclaims any duty to update the information in this press release. Contacts Media: Jeanene Timberlake RooneyPartners 646 …See details»
Organicell Announces Positive Results of Their Expanded Access …
Jun 15, 2021 Organicell has no intention and specifically disclaims any duty to update the information in this press release. Contacts Jeanene Timberlake RooneyPartners 646-770 …See details»